English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
抽象的な
Biomedical Uses for Engineered Heparin-Based Materials
Cheng Liu
Engineered heparin-based biomaterials have emerged as a versatile and promising class of materials with diverse biomedical applications. Leveraging the inherent bioactivity of heparin and advances in material engineering, researchers have developed tailored biomaterials that exhibit unique properties for applications ranging from drug delivery and tissue engineering to wound healing and diagnostics [1]. This article provides a comprehensive overview of the multifaceted potential of engineered heparin-based biomaterials. It explores their design principles, interactions with biological systems, and implications for various biomedical domains. Through a synthesis of current research, this article highlights the transformative impact of these biomaterials and discusses their role in shaping the future of modern medicine [2].